Gene · 23186
Papers2,104
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,104
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targeted plasma proteomics reveals organ damage signatures of AIDS- and noncommunicable disease-related deaths in people with HIV. | Nat Commun | 2025 | 40274826 | PubTator, text mining | PubMed |
| HKDC1 promotes colorectal cancer progression by regulating RCOR1 expression to activate the Wnt/β-catenin pathway, enhancing proliferation, migration, and epithelial-mesenchymal transition. | J Biol Chem | 2025 | 40209953 | PubTator, text mining | PubMed |
| Pharmacogenomics of chemotherapy induced peripheral neuropathy using an electronic health record-derived definition: a genome-wide association study. | Support Care Cancer | 2025 | 40198382 | PubTator, text mining | PubMed |
| Structural mimicry of UM171 and neomorphic cancer mutants co-opts E3 ligase KBTBD4 for HDAC1/2 recruitment. | Nat Commun | 2025 | 40175372 | PubTator, text mining | PubMed |
| Lysine Demethylase 1 Has Demethylase-Dependent and Non-Canonical Functions in Myofibroblast Activation in Systemic Sclerosis. | Cells | 2025 | 40136682 | PubTator, text mining | PubMed |
| The CoREST complex is a therapeutic vulnerability in malignant peripheral nerve sheath tumors. | Sci Rep | 2025 | 40128216 | PubTator, text mining | PubMed |
| CRISPR screening reveals ZNF217 as a vulnerability in high-risk B-cell acute lymphoblastic leukemia. | Theranostics | 2025 | 40093906 | PubTator, text mining | PubMed |
| Converging mechanism of UM171 and KBTBD4 neomorphic cancer mutations. | Nature | 2025 | 39939763 | PubTator, text mining | PubMed |
| UM171 glues asymmetric CRL3-HDAC1/2 assembly to degrade CoREST corepressors. | Nature | 2025 | 39939761 | PubTator, text mining | PubMed |
| A CRISPR-Cas9 screen reveals genetic determinants of the cellular response to decitabine. | EMBO Rep | 2025 | 39930152 | PubTator, text mining | PubMed |
| Inactivation of TACC2 epigenetically represses CDKN1A and confers sensitivity to CDK inhibitors. | Med | 2025 | 39793578 | PubTator, text mining | PubMed |
| A TBX2-driven signaling switch from androgen receptor to glucocorticoid receptor confers therapeutic resistance in prostate cancer. | Oncogene | 2025 | 39702503 | PubTator, text mining | PubMed |
| Conserved helical motifs in the IKZF1 disordered region mediate NuRD interaction and transcriptional repression. | Blood | 2025 | 39437550 | PubTator, text mining | PubMed |
| Novel Genetic Loci in Early-Onset Gout Derived From Whole-Genome Sequencing of an Adolescent Gout Cohort. | Arthritis Rheumatol | 2025 | 39118347 | PubTator, text mining | PubMed |
| Targeting the Epigenome Reduces Keloid Fibroblast Cell Proliferation, Migration, and Invasion. | J Invest Dermatol | 2025 | 39009280 | PubTator, text mining | PubMed |
| Nuclear KRT19 is a transcriptional corepressor promoting histone deacetylation and liver tumorigenesis. | Hepatology | 2025 | 38557414 | PubTator, text mining | PubMed |
| FOXK1 promotes hormonally responsive breast carcinogenesis by suppressing apoptosis. | Animal Model Exp Med | 2025 | 38238876 | PubTator, text mining | PubMed |
| The CoREST complex inhibitor, corin, leads to decreased tumor growth, increased cellular differentiation and extended lifespan in atypical teratoid rhabdoid tumor xenograft models. | bioRxiv | 2024 | 39763800 | PubTator, text mining | PubMed |
| CoREST Complex Inhibition Alters RNA Splicing to Promote Neoantigen Expression and Enhance Tumor Immunity. | bioRxiv | 2024 | 39713349 | PubTator, text mining | PubMed |
| Circular Engineered Sortase for Interrogating Histone H3 in Chromatin. | J Am Chem Soc | 2024 | 39585806 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23186/papers?page=4